![Reversal of rivaroxaban-induced anticoagulation with prothrombin complex concentrate, activated prothrombin complex concentrate and recombinant activated factor VII in vitro - Thrombosis Research Reversal of rivaroxaban-induced anticoagulation with prothrombin complex concentrate, activated prothrombin complex concentrate and recombinant activated factor VII in vitro - Thrombosis Research](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2092079146/2076391992/gr1.jpg)
Reversal of rivaroxaban-induced anticoagulation with prothrombin complex concentrate, activated prothrombin complex concentrate and recombinant activated factor VII in vitro - Thrombosis Research
![Swiss Medical Weekly - Initial experience with minimally invasive extracorporeal circulation in coronary artery bypass graft reoperations Swiss Medical Weekly - Initial experience with minimally invasive extracorporeal circulation in coronary artery bypass graft reoperations](https://smw.ch/rsrc/jf?tx_swajournal_file%5Baction%5D=index&tx_swajournal_file%5Bcontroller%5D=File&tx_swajournal_file%5Bidentifier%5D=smw.2022.w30101&tx_swajournal_file%5Bjournal%5D=ezm_smw&tx_swajournal_file%5Blanguage%5D=en&tx_swajournal_file%5Bmode%5D=view&tx_swajournal_file%5Bresource%5D=http%3A%2F%2Fprodclient.emh02.snowflakehosting.ch%2Fapi%2Ffile%2Fproduction%2F31%2F317cd93d38f6864bd502f3dc5c5f235746ce4752%2Fw30101_head.jpg&tx_swajournal_file%5Btype%5D=article)
Swiss Medical Weekly - Initial experience with minimally invasive extracorporeal circulation in coronary artery bypass graft reoperations
![Activated Clotting Time Testing Market – Global Industry Trends and Forecast to 2028 | Data Bridge Market Research Activated Clotting Time Testing Market – Global Industry Trends and Forecast to 2028 | Data Bridge Market Research](https://www.databridgemarketresearch.com/media/2021/5/a31e208d-a300-430d-a499-f17f16251b15.jpg)
Activated Clotting Time Testing Market – Global Industry Trends and Forecast to 2028 | Data Bridge Market Research
![Sensors | Free Full-Text | Evolving Paradigm of Prothrombin Time Diagnostics with Its Growing Clinical Relevance towards Cardio-Compromised and COVID-19 Affected Population | HTML Sensors | Free Full-Text | Evolving Paradigm of Prothrombin Time Diagnostics with Its Growing Clinical Relevance towards Cardio-Compromised and COVID-19 Affected Population | HTML](https://www.mdpi.com/sensors/sensors-21-02636/article_deploy/html/images/sensors-21-02636-g002.png)
Sensors | Free Full-Text | Evolving Paradigm of Prothrombin Time Diagnostics with Its Growing Clinical Relevance towards Cardio-Compromised and COVID-19 Affected Population | HTML
![Thromboelastometry for the assessment of coagulation abnormalities in early and established adult sepsis: a prospective cohort study – topic of research paper in Clinical medicine. Download scholarly article PDF and read for Thromboelastometry for the assessment of coagulation abnormalities in early and established adult sepsis: a prospective cohort study – topic of research paper in Clinical medicine. Download scholarly article PDF and read for](https://cyberleninka.org/viewer_images/243666/f/1.png)
Thromboelastometry for the assessment of coagulation abnormalities in early and established adult sepsis: a prospective cohort study – topic of research paper in Clinical medicine. Download scholarly article PDF and read for
![Correlation between activated clotting time monitoring and heparin concentration measurement in a patient with antiphospholipid syndrome during cardiac valve surgery: a case report | SpringerLink Correlation between activated clotting time monitoring and heparin concentration measurement in a patient with antiphospholipid syndrome during cardiac valve surgery: a case report | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40981-021-00427-x/MediaObjects/40981_2021_427_Fig1_HTML.png)
Correlation between activated clotting time monitoring and heparin concentration measurement in a patient with antiphospholipid syndrome during cardiac valve surgery: a case report | SpringerLink
![Limitations of activated clotting time (ACT) in heparin monitoring with... | Download Scientific Diagram Limitations of activated clotting time (ACT) in heparin monitoring with... | Download Scientific Diagram](https://www.researchgate.net/profile/Kriton-Filos/publication/12780041/figure/fig4/AS:341459313152008@1458421652680/Limitations-of-activated-clotting-time-ACT-in-heparin-monitoring-with-cardiopulmonary.png)
Limitations of activated clotting time (ACT) in heparin monitoring with... | Download Scientific Diagram
![In vitro effects of emicizumab on activated clotting time in blood samples from cardiac surgical patients - Tanaka - - Haemophilia - Wiley Online Library In vitro effects of emicizumab on activated clotting time in blood samples from cardiac surgical patients - Tanaka - - Haemophilia - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/bf3e0b1a-6c1e-4e05-a7ea-dc8656cb30dc/hae14452-fig-0001-m.jpg)
In vitro effects of emicizumab on activated clotting time in blood samples from cardiac surgical patients - Tanaka - - Haemophilia - Wiley Online Library
![Microorganisms | Free Full-Text | Prothrombin Time, Activated Partial Thromboplastin Time, and Fibrinogen Reference Intervals for Inbred Strain 13/N Guinea Pigs (Cavia porcellus) and Validation of Low Volume Sample Analysis | HTML Microorganisms | Free Full-Text | Prothrombin Time, Activated Partial Thromboplastin Time, and Fibrinogen Reference Intervals for Inbred Strain 13/N Guinea Pigs (Cavia porcellus) and Validation of Low Volume Sample Analysis | HTML](https://www.mdpi.com/microorganisms/microorganisms-08-01127/article_deploy/html/images/microorganisms-08-01127-g001.png)
Microorganisms | Free Full-Text | Prothrombin Time, Activated Partial Thromboplastin Time, and Fibrinogen Reference Intervals for Inbred Strain 13/N Guinea Pigs (Cavia porcellus) and Validation of Low Volume Sample Analysis | HTML
![JCM | Free Full-Text | Running after Activated Clotting Time Values in Patients Receiving Direct Oral Anticoagulants: A Potentially Dangerous Race. Results from a Prospective Study in Atrial Fibrillation Catheter Ablation Procedures JCM | Free Full-Text | Running after Activated Clotting Time Values in Patients Receiving Direct Oral Anticoagulants: A Potentially Dangerous Race. Results from a Prospective Study in Atrial Fibrillation Catheter Ablation Procedures](https://www.mdpi.com/jcm/jcm-10-04240/article_deploy/html/images/jcm-10-04240-g004.png)
JCM | Free Full-Text | Running after Activated Clotting Time Values in Patients Receiving Direct Oral Anticoagulants: A Potentially Dangerous Race. Results from a Prospective Study in Atrial Fibrillation Catheter Ablation Procedures
![Most recent version of the transfusion and coagulation algorithm [35].... | Download Scientific Diagram Most recent version of the transfusion and coagulation algorithm [35].... | Download Scientific Diagram](https://www.researchgate.net/profile/Oliver-Theusinger/publication/317185114/figure/fig1/AS:792048131141632@1565850398219/Most-recent-version-of-the-transfusion-and-coagulation-algorithm-35-ACT-activated.png)
Most recent version of the transfusion and coagulation algorithm [35].... | Download Scientific Diagram
![Activated Clotting Time (ACT) and Outcomes During PCI for NSTEMI: Insights from FUTURA OASIS-8 | tctmd.com Activated Clotting Time (ACT) and Outcomes During PCI for NSTEMI: Insights from FUTURA OASIS-8 | tctmd.com](https://s3.amazonaws.com/prod.tctmd.com/public/styles/large_slide_teaser/public/2015-04/128521.png?itok=h5KwPjk7)
Activated Clotting Time (ACT) and Outcomes During PCI for NSTEMI: Insights from FUTURA OASIS-8 | tctmd.com
![PDF) The use of the activated clotting time for monitoring heparin therapy in critically ill patients PDF) The use of the activated clotting time for monitoring heparin therapy in critically ill patients](https://i1.rgstatic.net/publication/10892780_The_use_of_the_activated_clotting_time_for_monitoring_heparin_therapy_in_critically_ill_patients/links/5725c84f08ae262228ae0240/largepreview.png)
PDF) The use of the activated clotting time for monitoring heparin therapy in critically ill patients
![Effect of abciximab versus tirofiban on activated clotting time during percutaneous intervention and its relation to clinical outcomes—observations from the TARGET trial - American Journal of Cardiology Effect of abciximab versus tirofiban on activated clotting time during percutaneous intervention and its relation to clinical outcomes—observations from the TARGET trial - American Journal of Cardiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/c4705b58-b01b-42d8-8d87-2d7d9d10bb99/gr1.gif)
Effect of abciximab versus tirofiban on activated clotting time during percutaneous intervention and its relation to clinical outcomes—observations from the TARGET trial - American Journal of Cardiology
![Activated Clotting Time (ACT) and Outcomes During PCI for NSTEMI: Insights from FUTURA OASIS-8 | tctmd.com Activated Clotting Time (ACT) and Outcomes During PCI for NSTEMI: Insights from FUTURA OASIS-8 | tctmd.com](https://s3.amazonaws.com/prod.tctmd.com/public/2015-04/128521.png)
Activated Clotting Time (ACT) and Outcomes During PCI for NSTEMI: Insights from FUTURA OASIS-8 | tctmd.com
![Epac1-deficient mice have bleeding phenotype and thrombocytes with decreased GPIbβ expression | Scientific Reports Epac1-deficient mice have bleeding phenotype and thrombocytes with decreased GPIbβ expression | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-017-08975-y/MediaObjects/41598_2017_8975_Fig1_HTML.jpg)
Epac1-deficient mice have bleeding phenotype and thrombocytes with decreased GPIbβ expression | Scientific Reports
![JCM | Free Full-Text | Activated Clotting Time Monitoring during Atrial Fibrillation Catheter Ablation: Does the Anticoagulant Matter? | HTML JCM | Free Full-Text | Activated Clotting Time Monitoring during Atrial Fibrillation Catheter Ablation: Does the Anticoagulant Matter? | HTML](https://www.mdpi.com/jcm/jcm-09-00350/article_deploy/html/images/jcm-09-00350-g001.png)